Capsid-mediated chromatin state of the AAV vector genome controls host species range
Kay, M.; Gonzalez-Sandoval, A.; Tsuji, S.; Zhang, F.; Hung, K. L.; Chang, H.; Pekrun, K.
Show abstract
Recombinant adeno-associated viral vectors (rAAVs) are among the most commonly used vehicles for in vivo based gene therapies. However, it is hard to predict which AAV capsid will provide the most robust expression in human subjects due to the observed discordance in vector-mediated transduction between species. We used a primate specific capsid, AAV-LK03, and demonstrated that the limitation of this capsid towards transduction of mouse cells was unrelated to cell entry and nuclear transport but rather due to depleted histone H3 chemical modifications related to active transcription, namely H3K4me3 and H3K27ac, on the vector DNA itself. A single-amino acid insertion into the AAV-LK03 capsid enabled efficient transduction and the accumulation of active histone marks on the vector chromatin in mouse without compromising transduction efficiency in human cells. Our study suggests that the capsid protein itself is involved in determining the chromatin status of the vector genome, most likely during the process of uncoating. Programming viral chromatin states by capsid design may enable facile DNA transduction between vector and host species.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Human cell surface-AAV interactomes identify LRP6 as blood-brain-barrier transcytosis receptor and immune cytokine IL3 as AAV9 binder 98%
- Projection-TAGs enable multiplex projection tracing and multi-modal profiling of projection neurons 96%
- Enhanced RNA-targeting CRISPR-Cas technology in zebrafish 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.